• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

combo

  1. Myrbetriq Sales

    Been out a while. Has Myrbetriq hit the number #1 prescribed OAB agent? Or Has the fact Vesicare is going generic stopped that? What about the fact a combo drug with those two will have crap coverage? How are the feeling of the sales force?
    • anonymous
    • Thread
    • combo depression myrbetriq
    • Replies: 3
    • Forum: Astellas
Top Bottom
Back